Activity

The purpose of this study was to analyze the validity and the reliability of the intensity ranges, number of actions and changes of direction measured by a commercial inertial measurement unit. Eleven elite youth futsal players performed a circuit with different type of displacements as sprinting, running at low-medium intensity, standing up and changes of direction. Data recorded by the Overtraq system were compared with video-analyzer during the six trials of each player. Standard error mean, Intraclass Correlation Coeficient and Coefficient of variation, were calculated to analyze the reliability of the device, as well as the Root Mean Square Error and Confidence Interval with correlation of Pearson for its validity. The results reported good validity for three intensity ranges (R2>0.7) with high reliability (Intraclass Correlation Coeficient 0.8-0.9), especially for high intensity actions (Intraclass Correlation Coeficient 0.95, Coefficient of Variation 3.06%). Furthermore, the validity for the number of different actions was almost perfect (96.3-100%), with only small differences regarding changes of activity (mean error 2.0%). The Overtraq system can be considered as a valid and reliable technology for measuring and monitoring actions at different intensities and changes of direction in futsal, likewise common actions for other indoor sports.Abuse of anabolic-androgenic steroids (AASs) is suspected to increase the risk of cardiovascular disease (CVD) and cardiovascular mortality in otherwise healthy individuals. AAS abuse may increase the incidence of CVD by altering the hemostatic balance toward a procoagulant state. Studies on the effect of AAS abuse on the fibrinolytic system, however, have either demonstrated a profibrinolytic effect or no effect of AAS abuse, but the overall effect of AAS on fibrinolysis has not been addressed so far. This cross-sectional study investigated the effect of AAS on fibrin clot lysis, fibrin structure, and the hemostatic proteins, potentially affecting these measures in current and former AAS abusers and healthy age-matched controls. The study population consisted of 37 current and 33 former AAS abusers, along with 30 healthy age-matched controls. Fibrin clot lysis, fibrin structure properties, fibrinogen, coagulation factor XIII (FXIII) plasminogen, plasmin inhibitor, plasminogen activator inhibitor-1 (PAI-1), and thrombin activatable fibrinolysis inhibitor (TAFI) were determined. Fibrin clot lysis was significantly reduced in participants abusing AAS compared with former abusers and controls (p  0.05). In conclusion, AAS abuse depresses fibrin clot lysis. This effect is not associated with alterations in fibrin structure but is rather caused by increased plasma concentrations of fibrinogen, FXIII, and plasmin inhibitor. These findings suggest that AAS abuse may be associated with increased thrombotic disease.The risk of venous thrombosis (VT) varies according to the type of progestogen that is found in combined oral contraceptives (COCs). When combined with the estrogen component ethinylestradiol (EE), the androgenic progestogens are better able to counteract the EE-induced stimulation of liver proteins and hence are associated with a twofold decreased risk of VT compared with non- or antiandrogenic progestogens, which exert limited counteraction of EE. Because EE is responsible for the increased risk, novel estrogens such as estradiol were developed and seem to have a lower risk of VT than EE. Besides COCs, there are other methods of hormonal contraceptives, such as progestogen-only contraceptives, which do not increase VT risk, except for injectables. selleck chemicals Other nonoral contraceptives are combined vaginal rings and patches. There is insufficient evidence regarding the risk of VT associated with these two methods compared with COCs. The increased risk associated with COCs is more pronounced in women with inherited thrombophilia. In these women, the progestogen levonorgestrel seems to be associated with the lowest risk of VT. Currently, there are no studies that have investigated the risk of VT in women who switch COCs. We hypothesize that switching COCs, even when switching from a high- to a low-risk COC, increases the risk of VT. Finally, risk prediction models in women who use COCs are lacking. Since there is a large number of VT cases associated with COC use, it is important to identify women at risk of VT and advise them on alternative contraception methods.

 The aim of this study was to evaluate the frequency of foramen cecum and dens in dente, and to verify the association of these structures in the maxillary lateral incisor (MLI).

 The presence of foramen cecum in the lingual surface of 110 MLI was verified, and the teeth were radiographed to observe the presence of dens in dente, being classified according to the literature. An association study between the presence of foramen cecum and dens in dente was performed using the Cramer’s V and chi-square statistical tests.

 The association was statistically significant between the foramen cecum and the dens in dente. Concomitant presence was observed in 17.27%, being a high rate when compared with the presence of foramen cecum alone (9.09%) or dens in dente alone (8.18%). In addition, type I (minimal invagination, confined to the crown of the tooth and not extending beyond the level of the cementum-enamel junction) was the most frequent (82.14%).

 We emphasize the importance of alerting the dentist to the presence of a foramen cecum on the lingual surface of the MLI, as it is likely that dens in dente is usually of type I. Thus, the foramen cecum is a sign that can assist the dental surgeon in the discovery of dens in dente and clinical conduct to be taken.

 We emphasize the importance of alerting the dentist to the presence of a foramen cecum on the lingual surface of the MLI, as it is likely that dens in dente is usually of type I. Thus, the foramen cecum is a sign that can assist the dental surgeon in the discovery of dens in dente and clinical conduct to be taken.The following AWMF guideline (DGGG/AGG & DEGUM responsible) deals with the diagnosis, screening and management of twins as well as the timing and mode of birth.Twin pregnancies can be classified as dichorionic diamniotic (DC DA), monochorionic diamniotic (MC DA) and monochorionic monoamniotic (MC MA) which are always monochorionic.Twin pregnancies can be concordant (both twins are affected) or discordant (only one twin is affected) for chromosomal defects, malformations, growth restriction and hemodynamic disorders.Chorionicity is the prognostically most significant parameter. Monochorial twins have significantly higher risks of intrauterine morbidity and mortality compared to dichorial twins.In particular, general aspects of twin pregnancies such as dating, determination of chorionicity and amnionicity, the labeling of twin fetuses and the perinatal switch phenomenon are discussed.Routine monitoring of MC and DC twin pregnancies with ultrasound at 11-13+ 6 weeks of gestation for chromosomal defects, invasive prenatal diagnosis, first-trimester NT or CRL discrepancies, early diagnosis of fetal anatomical defects, and management of twins with abnormalities, including selective fetocide, is described.